A Novel Strategy of ECMO Management Using Nafamostat for Regional Combined With Low Intensity Systematic Anticoagulation

Abroad (travel likely)Recruiting

Conditions

ECMO

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Bing Sun, Beijing, Beijing Municipality, China
Contact: Study coordinator (Bing Sun, MD) · ricusunbing@126.com · +8613911151075
Contact: Study coordinator (Li Wang, B.S.Nurs) · mu0mu0@yeah.net · +8615910268323

Study leads

Bing Sun, MD
Principal Investigator
Beijing Chao Yang Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Comparing a Suture-based System for the Removal of Arterial and Veinous ECMO Cannulas to the Standard Approach

VA-ECMO

Abroad (travel likely)Recruiting

Frankfurt, Germany · Mainz, Germany

Plasma Biomarkers and Platelet Morphology of Extracorporeal CardioPulmonary Resuscitation

ExtraCorporeal Membrane Oxygenation (ECMO) · Cardiac Arrest

Abroad (travel likely)Recruiting

Zhengzhou, China

Pre-Emptive LAVA-ECMO for Complex High-Risk TAVR

Severe Aortic Stenosis · Cardiogenic Shock · Cardiogenic Shock, ECMO

Abroad (travel likely)Recruiting

Detroit, United States · Morristown, United States

Use of Nafamostat Mesilate for Anticoagulation in Patients With ECMO

Extracorporeal Membrane Oxygenation Complication

Abroad (travel likely)Recruiting

Beijing, China